No abstract available
MeSH terms
-
Arteriosclerosis / etiology
-
Cerebrovascular Disorders / etiology
-
Cholesterol, HDL / blood
-
Cholesterol, LDL / blood
-
Clofibrate / therapeutic use
-
Coronary Disease / etiology
-
Eicosapentaenoic Acid / therapeutic use
-
Humans
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
-
Hyperlipidemias / drug therapy*
-
Hyperlipidemias / etiology*
-
Hypolipidemic Agents / therapeutic use
-
Kidney Failure, Chronic / complications*
-
Lipoproteins, VLDL / blood
-
Niceritrol / therapeutic use
-
Peripheral Vascular Diseases / etiology
-
Peritoneal Dialysis, Continuous Ambulatory / adverse effects
-
Renal Dialysis / adverse effects*
-
Triglycerides / blood
Substances
-
Cholesterol, HDL
-
Cholesterol, LDL
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors
-
Hypolipidemic Agents
-
Lipoproteins, VLDL
-
Triglycerides
-
very low density lipoprotein triglyceride
-
Eicosapentaenoic Acid
-
Niceritrol
-
Clofibrate